Trial intelligence / Profile preview

Collagenase and Needle Aponeurotomy for Dupuytren's Disease

NCT01776892Phase 3Withdrawn

Sponsor
University of Alberta
Start
May 2013
Primary completion
Mar 2014
Modality
Therapeutic Enzymes
Countries
1
01

Overview

A Phase 3 trial of collagenase clostridium histolyticum in Dupuytren contracture, sponsored by University of Alberta. Planned start May 2013; status: withdrawn.

02

Drugs

collagenase clostridium histolyticum
03

Conditions

Dupuytren contracture

Beyond the preview

Go deeper on NCT01776892.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01776892.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call